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LIST OF ABBREVIATIONS 
AMPA: α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid; 
ATP: Adenosine triphosphate 
[Ca2+]i: Intracellular calcium concentration; 
CNS: Central Nervous System; 
GABA: γ-aminobutyric acid; 
GluR: Glutamate receptor; 
KATP channels: ATP-dependent potassium channels 
mGluR: Metabotropic glutamate receptor; 
NMDA: N-methyl-D-aspartate; 
NR: NMDA receptor subunit: 
ROS: Reactive oxygen species; 
SK channels: Ca2+-activated potassium channels of small conductance 
VTA: Ventral tegmental area;  
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ABSTRACT 
Positive and negative reinforcing systems are part of the mechanism of drug 
dependence. Drugs with abuse potential may change the manner of response to negative 
emotional stimuli, activate positive emotional reactions and possess primary reinforcing 
properties. Catecholaminergic and peptidergic processes are of importance in these 
mechanisms. Current research needs to understand the types of adaptations that underlie 
the particularly long-lived aspects of addiction. Presently, glutamate is candidate to play 
a role in the enduring effects of drugs of abuse. For example, it participates in the 
chronic pathological changes of corticostriatal terminals produced by methamphetamine. 
At the synaptic level, a link between over-activation of glutamate receptors, [Ca2+]i 
increase and neuronal damage has been clearly established leading to 
neurodegeneration. Thus, neurodegeneration can start after an acute over-stimulation 
whose immediate effects depend on a diversity of calcium-activated mechanisms. If 
sufficient, the initial insult results in calcification and activation of a chronic on-going 
process with a progressive loss of neurons. At present, long-term effects of drug 
dependence underlie an excitotoxicity process linked to a polysynaptic pathway that 
dynamically regulates synaptic glutamate. Retaliatory mechanisms include energy 
capability of the neurons, inhibitory systems and cytoplasmic calcium precipitation as 
part of the neuron-glia interactions. This paper presents an integrated view of these 
molecular and cellular mechanisms to help understand their relationship and 
interdependence in a chronic pathological process that suggest new targets for 
therapeutic intervention. 
 
KEYWORDS: Calcium precipitation, Central Nervous System; Addiction; Drug abuse; 
Excitotoxicity; Glutamate; Neurodegeneration.  
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INTRODUCTION 
Long-term neurological effects are inherent to acute and chronic drug abuse and the 
complex phenomenon that results from interaction between a variety of biologic and 
molecular factors remains difficult to address. This is in part due to the absence of clear, 
long-term markers of drug use and to the limited models that investigate the whole 
process of drug abuse and addiction in specific brain areas. Besides none of these 
models reproduces all the human features, the usefulness of each one depends in large 
part on its validity as simulation of human behaviour. Many acute and chronic animal 
models associated with different paradigms are aimed at the determination of the 
involvement of neurotransmitters like serotonin, dopamine, noradrenaline, endo-
cannabinoids, γ-aminobutyric acid (GABA) or glutamate in several brain areas, at the 
investigation of specific aspects of the drug effects or at the analysis of the drug 
addiction process, The behavioural paradigms of euphoria and rewarding effects, 
including self-stimulation, self-administration, and conditioned place-preference 
models, are mostly used for the identification of the neuronal pathways involved in 
addiction [1;2]. All addictive drugs facilitate dopamine transmission and produce 
alterations in other neurotransmitters. For example, repeated cocaine produces in the rat 
a marked dopamine and glutamate release in nucleus accumbens and other areas such as 
ventral tegmental area and striatum [3] and ectasy abuse results in increased serotonin, 
dopamine and noradrenaline release [4]. The animal model with self-administration by 
various routes (e.g., oral, intragastric, intravenous, intracranial) is still the gold standard 
for assessing the rewarding properties of drug abuse and is commonly used for the 
preclinical assessment of the abuse liability of new agents [5]. In this model, 
experimental animals, normally a rat or a monkey are tested in a chamber containing a 
lever. Animals are trained to perform an operant task and drug delivery is made 
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contingent on the performance of an operant response, typically lever pressing or nose 
poking. With this technique, normal animal behaviour (e.g., grooming, feeding and 
drinking) can be studied concurrently with drug self-administration, but not the 
complexity of the molecular events. 
In recent years knockout mice have helped identify the proteins mostly in charge of a 
specific response or behaviour [6]. Mice lacking a specific receptor, transporter or 
enzyme are used to determine whether this molecule plays a key role in the acute 
response or the addiction process [7]. For example, mice lacking the µ receptor neither 
exhibit the behavioural effects nor become physically dependent when given opioids. 
Reverse genetic approaches is also applied to identify the underlying molecular 
components. Thus, models lacking a dopamine transporter, noradrenaline transporter or 
vesicular monoamine transporter and exposed to psychostimulants, tricyclic 
antidepressants or reserpine present an enhanced behavioural response explained by the 
direct or indirect dopamine receptor activation  
Alcoholism, an example of polygenic disorder, depends on gene-environment 
interactions [8]. Its chronic ingestion alters multiple pathways and modifies the 
serotonin, nicotinic, γ-aminobutyric (GABA)A, N-methyl-D-aspartate (NMDA) and µ 
and δ  receptors. The absence of alcohol self-administration behaviour in µ receptor-k.o 
mice has been determinant to strongly involve this receptor and clarify, in part, the 
addiction process.  
The ventral tegmental area (VTA) is necessary for the processing of rewarding of drugs 
of abuse, where they rapidly potentiate excitatory synapses on dopaminergic neurons, 
and alter GABAergic synapses. However, whereas the nature of the main pathway 
initially involved, the function of proteins that regulate pre- and postsynaptic glutamate 
neurotransmission appears modified in several brain areas. To illustrate the key 
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participation of glutamatergic transmission in circuits involved in drug abuse, cocaine, 
amphetamine and ethanol molecular actions are considered in more details. 
 
GLUTAMATE NEUROTRANSMISSION, REWARD CIRCUIT AND DRUGS OF 
ABUSE 
The involvement of interconnected circuits between prefrontal cortex, hippocampus, 
nucleus accumbens, VTA, and amygadala in the development of addiction and in the 
manifestation of addictive behaviours implies the participation of many 
neurotransmitters. These organized circuits have GABAergic, peptidergic and 
glutamateric outputs, and activation of glutamatergic synapses seems critical in the 
expression of addictive behaviours. Glutamatergic transmission accounts for up to 70% 
in the Central Nervous System (CNS), and there are glutamatergic projections and/or 
neurons expressing glutamate receptors in most circuitries, including the reward one. 
Thus, VTA and its different targeted regions, like nucleus accumbens, amygdaloid 
complex and frontal cortex receive substantial glutamatergic input [9]. Modification of 
glutamatergic function, a mechanism central to neuronal plasticity, is involved in short-
term and long-term drug effects. In this way, activation of glutamatergic pathways is a 
critical point in the development of addictive behaviours for a variety of drugs 
including, cocaine, heroin, nicotine and alcohol. As such, glutamate mediates numerous 
effects of acute and chronic exposure to cocaine. For example, metabotropic glutamate 
receptor 5 that has the potential to directly regulate neurons is essential for cocaine self-
administration and behaviour [10]. Acute administration induces a redistribution of α-
amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and NMDA receptors in 
the VTA and a reduction of various ionotropic glutamate receptor (GluR) subunits 
expression, like the GluR3, GluR4 and NMDA receptor subunit 1 (NR1) in the nucleus 
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accumbens. This may be viewed as a compensatory mechanism of the increased 
synaptic glutamate caused by cocaine, especially after high doses (30mg/kg, i.p.) [11]. 
Chronic administration results in behavioural sensitization to cocaine, with an increased 
responsiveness of the dopamine mesolimbic system to glutamate due to a specific 
increased responsiveness of AMPA receptors and an increased expression of GluR1 of 
the VTA [12;13]. Some authors have also found in this area a specific increase of NR1 
[14;15]. Because of the numerous procedural differences, changes in other GluR subunit 
expression as an adaptative response to repeated cocaine administration or withdrawal 
are not conclusive [16;17]. Because modifications are only detected associated with 
behavioural signs of sensitization; lack of data in other circumstances may overlook 
subtle changes, such as an increased surface expression of AMPA receptor subunits that 
remain to be clearly established [18;19]. In addition, involvement of glutamatergic 
transmission in cocaine reward, reinforcement and reinstatement has been clearly 
established by direct glutamatergic fibber stimulation or blockade of NMDA and 
AMPA VTA receptors [20;21]. However, how each component of the glutamatergic 
synapse participates and adapts to cocaine repeated exposure remains to be deciphered. 
Research with genetically modified mice currently in process may be the better choice 
to clarify the role of each proposed target. Preliminary results indicate a preponderant 
role of the Homer proteins in the behavioural sensitizing effects [22;23]. These proteins 
that link NMDA and metabotropic glutamate receptors (mGluR) with intracellular 
calcium stores might be reduced in cocaine reward behaviour.  
As for cocaine, increased overflow of glutamate is associated with amphetamine 
exposure [24;25]. In this condition, modifications of AMPA and mGlu receptor 
conductance underlie the well-known increased expression of c-fos and Zif268, and 
phosphorylation of transcription factors [26;27]. mGluR also mediate VTA neuron 
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plasticity induced by amphetamine [28]. Glutamatergic neurotransmission has been 
correlated with the neurotoxic effects of high doses of amphetamine [29]. However, the 
marked differences in glutamatergic neurotransmission caused by acute and chronic 
amphetamine exposures rise several questions related the plasticity of the glutamatergic 
synapse [30-32]. These questions mostly concern how modification of neuronal 
responsiveness takes place, how reduction in NMDA receptor components is 
accompanied by short and long-lasting modifications in AMPA and mGluR receptors, 
and how astroglia participates of these modifications. Finally, more research is also 
needed to better understand the role of glutamate in the reinforcement and relapse-
behaviour of amphetamine exposure. 
Research on glutamatergic neurotransmission and ethanol abuse is present from the late 
80-90. Before, ethanol increased membrane fluidity and potentation of GABAergic 
neurotransmission were considered as its two basic mechanisms of action. Presently, 
ethanol inhibition of NMDA receptors resulting in an up-regulation of various NMDA 
receptor subunits in a chronic ingest has been well established [33-35]. Thus, 
consistently, several NMDA receptor subunits (NR1, NR2A and NR2B) are increased 
in VTA, amygdala, cerebral cortex and hippocampus and support an increased 
conductance and cationic influx [36-38]. However, ethanol effects on glutamate 
overflow depends on its concentration: at low dose synaptic glutamate levels are 
increased, whereas they are reduced at high ethanol doses [39;40]. Astroglia has been 
suggested to participate in this paradoxical effect, but research is needed to clearly 
understand the underlying cellular and molecular mechanisms [41]. The same is true for 
the effects of withdrawal. Acute manifestations include increased synaptic glutamate 
and hyper-excitability whose intensity can reach seizure-like level [42;43]. One of the 
main questions to be presently answered by researchers is why these manifestations 
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increase in intensity after repeated withdrawal periods. This question relates with the 
elevated risk factor of cerebrovascular diseases such as stroke present in ethanol abuse 
[44;45]. Finally, exposure to ethanol during synaptogenesis of the developing CNS 
causes an important neuronal loss due to the pro-apoptotic effect of ethanol. As a result, 
the disruption of synaptic connections and massive neuronal death explain the 
diminished brain size and disturbances associated with the foetal alcohol syndrome. In 
rodents, this neuronal loss only requires a single low ethanol intoxication episode 
(80mg/dl-60min) to trigger neurodegeneration [46;47]. Besides its major interest, 
research of long-term effects of drug exposure on CNS maturation is presently limited 
by the available experimental models and required time of study. 
 
EXCITOTOXICITY AND NEURODEGENERATION 
In the early 1970s, Olney defined excitotoxicity as the neuropathological process 
triggered after over stimulation of excitatory amino acid receptors [48]. At present, 
excitotoxicity includes the concept of glutamate-mediated endogenous neurotoxicity; 
i.e. the putative excitotoxicity when glutamate increases in the extracellular space [49]. 
This concept is of interest because it presents the possibility of new strategies in 
pharmacological neuroprotection. It is generally accepted that excitotoxic injury to 
neurons results from excessive inward currents of Ca2+ and Na+ through glutamate-
operated ion channels -i.e. kainate, NMDA, or AMPA receptors-, supplemented by 
release of Ca2+ from intracellular stores subsequent to mGluR activation, leading to 
intracellular Ca2+ overload [50]. Excitotoxicity also involves an imbalance of 
transmembrane Na+, Cl- and K+ gradients, cell swelling [51] and formation of calcium 
precipitates in most CNS areas [52-54]. The complexity of the mechanisms involved in 
glutamatergic neurotransmission makes it already apparent that a number of 
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abnormalities, pre-synaptic, post-synaptic or glial, alone or in combination can be 
excitotoxic. For example, a loss of selectivity of ionotropic receptors [49], or 
deficiencies in glial re-uptake of glutamate [55] are observed in lateral amyotrophic 
sclerosis. In drug abuse, synaptic glutamate dysfunctions contribute to explain 
phenomena such as the effectiveness of either a mGluR1, mGluR5 or NMDA antagonist 
to inhibit the up regulation of endoplasmic reticulum stress protein due to acute and 
chronic cocaine administration [3]. 
Excessive glutamate-mediated excitation stands out as a critical factor common to 
neurodegeneration [49;50;56]. Neurodegeneration can start after an acute injury whose 
immediate effects depend on a diversity of Ca2+ activated injuring and compensatory 
mechanisms. For example, opioid blockade of long-term potentiation of GABAA- 
mediated transmission onto dopamine neurons in the VTA potentiates excitatory 
synapses [57], and may activate a chronic on-going neurodegenerative process. This 
sustained over-stimulation of glutamatergic synapses also observed after high doses of 
methamphetamine results in an excitotoxic process with a decrease in NMDA receptor 
binding and dopamine striatal content [58]. In fact, long-term dopamine toxicity 
associated with methamphetamine abuse is directly caused by glutamate receptor 
overstimualtion [59]. 
A link between intracellular calcium concentration ([Ca2+]i) increase, over-activation of 
excitatory amino acid receptors, and neuronal death has been established from data 
obtained in in vitro and in vivo models [60-62]. In animal models, excitotoxicity can be 
reproduced with low doses of glutamate agonist microinjections. Due to the high 
affinity of ionotropic glutamate receptors for specific agonists, NMDA, AMPA or 
kainate injected in non saturable conditions are able to trigger calcium-mediated 
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excitotoxicity in several rat brain areas and an on-going neurodegenerative process [63]. 
 
Fig. 1: Cellular and molecular alterations induced by drug abuse. Drug abuse implies 
overactivation of several pathways, including the glutamatergic one. The 
overstimulation of glutamate receptors results in an uncontrolled increase of [Ca2+]i and 
apoptotic or necrotic neuronal death. Positive feedback of the lesion induces glutamate 
release during the whole process (Adapted from [62]). 
 
Calcium overloading in cytosol and mitochondria plays a critical role in neuronal injury 
(Fig 1.), but the superfluous Ca2+ also induces release of several intrinsic and extrinsic 
factors that activate processes to rescue neurons from death [64-67]. As a result, and to 
support their low regenerative capacity and long life span, neurons may withstand very 
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large calcium insults through adaptative mechanisms. For example, in presence of 
excess phosphate, the formation of calcium phosphate complexes sequesters free 
calcium in neurons and astrocytes at no energy expense [68-71]. Dynamic changes in 
calcium movements after drug abuse are mainly associated with over-stimulation of 
dopamine and glutamate post-synaptic receptors leading to oxidative stress and toxic 
effects [72]. Thus, since cocaine increases levels of glutamate and dopamine, further 
[Ca2+]i increase depends directly o the graded receptor activation and on the 
participation of adaptive mechanisms. 
 
Brain calcification represents a new adaptative step of calcium homeostasis 
Glutamate receptor agonist microinjection in rat CNS mimics the intracellular Ca2+ 
precipitation present in human and canine degenerative process [52;63;73]. Similar 
calcification is also observed after blockade of synaptic glutamate re-uptake [55]. As 
these deposits are observed in several areas of rat brain after microinjection of different 
excitotoxins [63;71;73;74], their formation does not depend on the glutamate receptor 
subtype initially stimulated. However, their size, number and distribution vary with both 
the activated receptor and the CNS area. Ca2+ deposits do not occur in all cells that 
degenerate in response to excitotoxins. For example, in the basal forebrain and medial 
septum, the calcification observed in GABAergic cells was not detected in cholinergic 
neurons. The former, together with astrocytes, seem to participate actively in the 
calcification process [52;75]. X-ray microanalysis showed an electron-diffraction ring 
pattern which was characteristic of a crystalline structure similar to apatites [76], and a 
Ca/P ratio of 1.3±0.2 of cytoplasmic deposits (fig. 2), a ratio lower than the theoretical 
apatite value of 1.67. This ratio is also typical of biological crystals which do not have 
an ideal organization [71]. As biological hydroxyapatites, these deposits are similar to 
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those observed in several peripheral human tissues [77;78]. Therefore, calcification 
depends on the increase in intracellular inorganic phosphate (i.e. adenosine triphosphate 
(ATP) depletion) and, most importantly, on the degree of protein phosphorylation. 
Thus, the Ca2+-binding-protein-dependent kinases and the activity of neurotrophic factor 
ultimately control calcification. 
 
Fig. 2: Characterization of Ca2+ deposits. a) Intracellular Ca2+ viewed by TEM; note its 
acicular structure composed by several nanocrystals. b) X-ray microanalysis of a non-
osmificated brain sample with a calculated Ca/P ratio of 1.3. c) TEM image of a non-
osmificated deposit showing needle-shaped crystals. d) Electron-diffraction image with 
a four-ring pattern (arrowheads) similar to that of hydroxiapatite. Bars: a, 0.5 µm; b, 5 
µm; c, 0.2 µm. 
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Together with Ca2+ deposits, glutamate ionotropic receptor over-stimulation induces 
precipitation of uric acid and aluminosilicates, and the accumulation of sulphated 
mucosubstances [75]. The formation of these products may be related to the appearance 
of tissue compensatory mechanisms. Uric acid, the end product of adenosine and 
guanosine catabolism, increases after nucleic acid degradation, acts as antioxidant and 
protects mitochondria against glutamate-induced [Ca2+]i increase [79]. Moreover, 
adenosine inhibits neurotransmitter release and a balance between excitatory and 
inhibitory neurotransmission may prevent glutamate excitotoxicity [80;81]. 
Consequently, the concentration of uric acid increases during neurodegeneration [82] 
and, due to its limited solubility in physiological conditions, it easily precipitates as 
urate crystals. Crystallization of aluminosilicates may also be related to a compensatory 
mechanism of [Ca2+]i increase [83] because of the unique affinity of aluminium for 
silica acid. Precipitates of hydroxyaluminosilicates are therefore easily formed to reduce 
aluminium toxicity. Similar cerebral formations have been described in several 
pathologies such as Alzheimer’s or Fahr’s diseases, where they would have a similar 
role. The functional meaning of mucosubstance accumulation remains unclear. In vitro 
mineralization models indicate that glycosaminoglycans and proteoglycans are effective 
competitive inhibitors of hydroxiapatite formation and growth [84]. This suggests that 
their accumulation in brain may reduce [Ca2+]i through Ca2+ sequestration. However, if 
phosphorylated, they may participate directly in the nucleation of hydroxiapatite 
formation [84]. It should also be noted that, because of their high sulphur content, these 
mucosubstances may act as antioxidants  
The [Ca2+]i increment finally activates the mechanisms triggering neuronal death, Ca2+ 
extrusion and buffering are activated when the [Ca2+]i increases [62;85] with a great 
expenditure of energy through Ca2+-ATPases. The replacement of damaged molecules 
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also depends on ATP availability. Moreover, the high mitochondrial intake of Ca2+ can 
lead to a loss of the mitochondrial membrane potential and the production of reactive 
oxygen species (ROS), thereby decreasing cellular respiratory capacity. As a result, 
aerobic glycolysis accelerates during the period soon after acute excitotoxicity; 
however, because of the limited mitochondrial function, pyruvate is transformed into 
lactate with the only gain of 2 ATPs per molecule of glucose. Therefore limited ATP 
forces a reduction in astroglial energetic consumption to facilitate neuronal glucose 
availability [86] and helps maintain neuronal membrane polarity as a priority. In this 
situation, intracellular Ca2+ may precipitate as hydroxiapatite to reduce its cytoplasmic 
toxicity as well as the extrusion energy expenses in neurons and astrocytes. 
The massive astroglial production of lactate to help compensate neuronal energy 
depletion caused by excitotoxicity is a key factor in brain calcification. pH reduction 
associated with increased lactate concentration facilitates the solubility of Ca2+ and the 
formation of H2PO4-, HPO42- and PO43- ions from inorganic phosphate and 
phosphorylated proteins. Because of the very high Ca2+ / H2PO4-, HPO42-, PO43- affinity, 
apatite nucleation may occur with the subsequent growth of crystalline formation along 
with neurodegeneration (Fig 3.). If this is the case, calcification of each lesioned area 
depends not only on the density and subtype of glutamate receptors, phosphate 
availability and Ca2+ movements, but also on the differential capacity of glial cells to 
release lactate during degeneration. These concretions are intimately associated with 
mucopolysaccharides acting as templates that also help neutralize in the injured cell 
reactive oxygen species [75;87]. 
Evidence has been provided of a common pattern of brain calciﬁcation taking place in 
several human pathologies, and in the rat with glutamate-derived CNS lesions, 
regarding the chemical composition, physical characteristics, and histological 
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environment of the precipitates. Furthermore, a common physical mechanism of deposit 
formation through nucleation, lineal growth, and aggregation has been proposed, under 
the modulation of protein deposition and elemental composition factors [70]. Insofar as 
calcium precipitation reduces activity signals at no energy expense, the presence in 
human canine and rodent brain damage of a common pattern of calciﬁcation may reﬂect 
an imbalance between cellular signals of activity and energy availability for its 
execution. 
Fig. 3: Schematic drawing of the excitotoxic process induced by glutamate with 
calcium precipitation as an adaptative new step of Ca2+ homeostasis. The massive 
astroglial production of lactate that intends to adapt to the increased neuronal energy 
requirement caused by excitotoxicity is a key factor for brain calcification. pH reduction 
associated with increased lactate concentration facilitates the solubility of ions from 
inorganic phosphate and phosphorilated proteins. Because of the very high Ca2+ / 
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H2PO4-, HPO42-, and PO43-, affinity, apatite nucleation may easily occur with the 
subsequent growth of crystalline formation along with neurodegeneration. 
 
Finally, the lack of brain calcification long time after injection of low doses of 
excitotoxin qualifies calcification as an acute process. Due to this correlation established 
with acute but not chronic brain damage, the extension of calcification in a brain area 
depends on the intensity of the acute phase of each pathology [70;88]. Thus, the positive 
correlation between the calcified area of hippocampal formation and extension of 
damage found in blood flow neuropathies such as hypoxia-ischemia and vascular 
dementia [89], is not found in Alzheimer’s disease [70;88]. Calcium deposits present 
within the amyloid plaques of Alzheimer’s patients would reflect the compensatory 
mechanisms activated by the same plaque toxicity. To our knowledge, until now, no 
study has been done to assess the presence of brain calcification in drug addicts. If 
present it would reflect the cumulative effects of repeated acute damage rather than the 
chronic lesion. As said earlier, this would be expected in the periods of repeated 
withdrawal of chronic alcoholism, associated with an hyperactivity of the glutamatergic 
synapse. If true, calcification detection by brain imaging could be of major interest 
because of its strong correlation with neuronal death, as evidenced in perinatal human 
hypoxia-ischemia [88].  
 
Overstimulation, intracellular calcium increase and energy failure 
The increase in [Ca2+]i and the energetic loss can induce other interdependent 
mechanisms that underlie neuronal death, such as acidosis, ROS generation, and 
activation of proteases and endonucleases that trigger apoptotic death. 
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Excitotoxicity induces acidosis in cells and in the extracellular space [90]. There are 
several mechanisms by which pH decreases during neuronal injury. Mitochondrial 
damage forces the cell to a shift from aerobic to anaerobic metabolism; as a result 
lactate is produced with the formation of two ATPs and the release of two protons. 
After trauma and ischemia, extracellular lactate increases dramatically and the pH 
decreases. To ensure neuronal viability during and even after human hypoxia, glial 
glucose is oxidized only to lactate, which is rapidly transported into neurons for its 
complete oxidation [91]. Furthermore, H+ also appears during some chemical reactions 
such as phospholipid hydrolysis. In parallel, Ca2+ influx causes rapid cytoplasmic 
acidification through a) the activity of membrane Na+/H+ exchanger to restore the Na+ 
gradient, and b) the Ca2+-dependent displacement of protons bound to cytoplasmic 
anions [62]. 
Oxidative stress produced by methamphetamine is reflected by increases in lipid 
peroxidation, oxidized proteins in striatum and hippocampus, and reduction in striatal 
glutathione [92;93]. These toxic effects are the direct result of over-stimulation of 
GluRs, with the resultant activation of calcium-activated proteins. Agents that protect 
glutamate overflow protect from subsequent striatal toxicity, despite increases in 
synaptic dopamine [59]. High [Ca2+]i derived from drug acute effects can activate a 
Ca2+-dependent protease which catalyzes the xantine dehydrogenase conversion to 
xantine oxidase. It also can induce ATP degradation to hypoxantine, a substrate of 
xantine oxidase together with O2 the other substrate of the reaction. Consequently, 
xantine oxidase is strongly activated and produces large amounts of uric acid to prevent 
further oxidative damage. However, due to its limited solubility, uric acid may 
precipitate and thus participate to neuronal suffering [82]. 
 
19/48 
Protease activation, apoptosis and necrosis 
Activation of proteases of the caspase and calpain families can be triggered by Ca2+ 
influx and oxidative stress. Ca2+ overload also activates endonucleases, a series of Ca2+-
dependent enzymes that degrade DNA and that may be involved in two 
morphologically distinct forms of neuronal degeneration: necrosis and apoptosis [62]. 
Necrosis is a chaotic process that involves rapid energy loss, acute swelling, and 
vacuolation of the cell body and neurites with subsequent lysis of the cell, which spills 
the cells contents into the extracellular fluid. Apoptosis involves protein synthesis, 
compaction of the cell body, nuclear fragmentation, and formation of cell surface blebs 
that may prevent exposure of surrounding cells to the content of the dying cell [94]. The 
dysregulation of neuronal Ca2+ homeostasis during acute insults may result in excessive 
stimulation of calpains. Concerning caspases, there are at least two major pathways by 
which the initiator pro-caspases are activated in response to death-inducing stimuli and 
subsequently cleave the effector enzymes. Calpain is activated in most forms of necrosis 
and in some forms of apoptosis, while caspase 3 is only activated in neuronal apoptosis 
[95]. Calpains could become over-activated under extreme conditions that result in 
sustained elevation of cytosolic Ca2+ levels, which is generally associated with necrosis. 
Caspases, like calpains, are cytosolic cystein proteases, but do not require Ca2+ for 
activity [95], although they are also responsive to increase intracellular concentration of 
this ion. Calpains and caspases have a finite number of cellular proteins as substrates, 
including cytoskeletal proteins, enzymes involved in signal transduction, cell-cycle 
proteins, and nuclear-repairing proteins. Interestingly, NMDA and AMPA receptors 
also appear to be substrates for calpains and caspases. Collectively, these findings 
suggest key roles for caspases and calpains in modulating neuronal Ca2+ homeostasis 
and in preventing excitotoxic necrosis [96]. Additional calpain and caspase substrates 
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that may be involved in regulating plasticity have been identified in studies of two 
proteins linked to Alzheimer’s disease: β-amyloid precursor protein and presenilin-1. In 
addition to these two molecules, several other proteins linked to neurodegenerative 
disorders, such as amyotrophic lateral sclerosis and Parkinson’s disease, are caspase 
substrates.  
Although it was initially accepted that excitotoxicity leads to necrotic death, a wide 
continuous spectrum of situations between apoptosis and necrosis has been described 
[97]. The factors that determine the pattern of neuronal death seem to be the intensity of 
the lesion, the [Ca2+]i and the cellular energy capacity [98]; the apoptotic death is 
associated with a combination of all factors that results in a less severe injury. The cell 
then prevents the uncontrolled release of intracellular compounds (e.g. glutamate) and 
the subsequent inflammatory response of tissue. As ATP levels decrease, the necrotic 
process starts presenting a hybrid pattern of both neuronal deaths.  
 
RETALIATORY MECHANISMS AGAINST ACUTE SYNAPTIC 
OVERSTIMULATION 
Given these toxic effects, adaptations that act to control glutamatergic 
neurotransmission and calcium movements in the cell can potentially be protective. At a 
time scale, these defenses are developed to act at any moment during the excitotoxic 
event, involve different cellular types such as neurons, astrocytes and microglia, and 
deal with the cellular and molecular mechanisms of glutamatergic neurotransmission. 
These mechanisms include defenses that: a) decrease neuronal excitability, b) decrease 
glutamate accumulation in the synapse, c) limit calcium mobilization in the postsynaptic 
neuron and protect against calcium-dependent degenerative effects, and d) enhance 
neuronal energetic [99]. 
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Control of neuronal excitability 
Potassium channels are in charge of controlling the peak of action potentials, i. e. of the 
control of neuronal excitability. More than one hundred of genes encoding for proteins 
forming potassium channels have been described [100]. Within this heterogeneity two 
of those channels are proposed as defense against neuronal over-stimulation. Ca2+-
activated potassium channels of small conductance (SK channels) are present in a wide 
range of excitable and non-excitable cells. On activation by low concentrations of Ca2+, 
their opening results in hyperpolarization of the membrane potential and changes in 
cellular excitability [101]. SK channels play a key role in the spike-frequency 
adaptation and mediate the after-hyperpolarization that causes the refractory period 
[102]. As potentiation of the after-hyperpolarization by excessive cytosolic calcium 
would dampen the excitability, SK channels are ideally suited to transduce the calcium 
mobilization central to excitotoxic injury into a protective, hyperpolarizing signal.  
Other candidate to control cellular excitability during excitotoxicity is the ATP-
dependent potassium (KATP) channel, which opening in the hypothalamus is triggered 
by ATP depletion [103] in the hypothalamus. As a result, KATP channels can translate 
the energy depletion induced by any over-stimulation into a protective hyperpolarisation 
response. Thus, two reliable consequences of excitotoxic insults, the mobilization of 
cytosolic calcium and the depletion of ATP, would serve to activate potassium channels 
and decrease neuronal excitability in the face of a receptor over-stimulation. 
 
Decrease of synaptic accumulation of glutamate. 
Given the toxic effects of glutamate, adaptations that act to decrease its synaptic 
accumulation can potentially be protective. A number of the protective mechanisms 
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against a receptor over-stimulation are conducted to inhibit glutamate release during 
insults, and some of them involve retrograde signaling of inhibitory neurotransmitters 
and neuromodulators. Thus, GABA, taurine and adenosine present a retaliatory activity 
that has shown neuroprotective properties during glutamate-mediated neuronal insults 
[99]. For example, GABAergic retrograde signaling in hippocampus is multisynaptic, 
i.e. collaterals from glutamatergic pyramidal terminate on GABAergic interneurons 
which, in turn, inhibit glutamatergic neurons [104]. Astroglial taurine release during 
insults derived from potassium and water uptake decreases presynaptic neuronal 
excitability by increasing chloride influx [105]. Adenosine neuroprotective activity is 
accomplished through binding to A1 adenosine receptors linked by G proteins to both 
calcium and potassium channels [106]. Extracellular adenosine concentration increases 
after any acute brain injury to exert its protective actions. In this situation, extracellular 
adenosine increase finally results in an enhancement of uric acid level. Uric acid, a 
potent antioxidant, preserves mitochondrial activity and acts as a neuroprotective agent 
against the rise in glutamate induced intracellular calcium concentration [75;79]  
Two astroglial sodium-dependent transporters remove synaptic glutamate and transform 
it into glutamine by means of glutamine synthetase and ATP hydrolysis [107;108]. 
Glutamine is released and returns to presynaptic neurons, where glutaminase, present 
prominently in glutamatergic neurons, converts it back into glutamate [109]. The fine 
adaptation of the glutamate-glutamine cycle to neuronal activity and suffering is 
important to avoid excessive synaptic glutamate and neuronal death [110-112]. 
Enhancement of taurine released from glial cells decreases presynaptic excitability by 
binding to the GABAA [113] and glycine [114] receptors. By means of these 
interactions, taurine can help maintain the hippocampal inhibitory tone. In this line, 
adenosine modulation of glutamate activity also extends to the other systems. An 
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adenosine modulation of GABA activity has been proposed [81]. This hypothesis is 
supported by data showing that following ischemia, adenosine receptor agonists inhibit 
the cortical release of GABA. A reduction in glutamate turnover after adenosine A1 
receptor blockade indicates that adenosine participates in the control of the glutamate-
glutamine cycle through the modulation of glutamate transport by astrocytes [81]. These 
studies unveil an interdependency of all these processes, which coordinated adaptation 
and even the crosslink between their specific pathways are necessary to ensure control 
of neuronal excitability and receptor over-stimulation. 
 
Limitation of calcium mobilization and protection against calcium-dependent 
degenerative effects 
When cellular calcium homeostasis is overloaded, i. e. the sequestration systems (Ca2+-
binding proteins) are saturated and the extrusion ones are activated, Ca2+/Na+ antiporters 
and mitochondrial Ca2+ uniporter reduce intracytosolic calcium. When the first wave is 
stopped, Ca2+ binding proteins release Ca2+, which is extruded by the high efficiency 
cytoplasmatic plasma membrane calcium ATPases. A similar process takes place in 
mitochondria, the nuclear envelope-endoplasmic-reticulum network, and secretory 
vesicles (Fig. 4). All these systems, which maintain Ca2+ movements under homeostatic 
control, have a critical dependence on energy. Interplay between all of them constitutes 
a coordinated way to decrease the extent of calcium mobilization in response to 
glutamate. Calcium itself can mediate a negative feedback. Calcium-dependent 
activation of calcineurin and calmodulin can inhibit voltage-gated and NMDA-receptor-
gated calcium currents, respectively [99]. 
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Fig. 4: Schematic diagram of neuronal Ca2+ movements. Processes responsible Ca2+ 
extrusion are energy dependent. Processes for increases for cytosolic and nuclear Ca2+ 
are energy independent. (See text for details). 
 
Mitochondrial intake of Ca2+ decreases its electrochemical gradient; the opening of the 
permeability transition pore also dissipates a considerable percentile of membrane 
potential allowing free circulation of many ions through pores, and all extrusion 
systems. To restore the loss of electrochemical gradient and global ATP consumption, a 
fine controlled temporal stimulation of the mitochondrial respiratory chain is required. 
Any alteration of the energy metabolism affects Ca2+ homeostasis and vice-versa 
[115;116]. 
Calcium precipitation has been proposed as a putative free-energy defense that limit for 
calcium movements. Although the significance of cellular calcification is unknown, a 
number of points suggest that it is part of the compensatory mechanisms for excitotoxic 
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neurodegeneration. For example, the observation that mitochondria close to Ca2+ 
concretions appear normal at the electron microscopy level supports this hypothesis 
[71], despite the fact that mitochondrial dysfunction constitutes a primary event in 
NMDA-induced degeneration in cultured hippocampal neurons [117]. This hypothesis 
is also consistent with the finding that neurons undergoing prolonged stimulation of 
NMDA receptors can survive in the presence of [Ca2+]i chelators. Very high levels of 
cytoplasmic Ca2+ are not necessarily neurotoxic, and an effective uptake of this element 
into mitochondria is required to trigger NMDA-receptor-stimulated neuronal death 
[118]. Other results support this hypothesis. In rat globus pallidus, the AMPA-dose-
response study has shown a dose-dependent increase in calcification which was not 
accompanied by an increase in astrogliosis[63]. In hippocampus, AMPA induced a 
calcified area larger than the injured area. In this same structure, the selective 
adenosine-A2a-receptor antagonist 8-(3-chlorostyryl)-caffeine increased the NMDA-
induced neuronal loss while calcification was decreased [54]. Thus, all these data 
indicate that Ca2+ precipitation does not necessarily reflect neuronal death and that, as 
proposed for retinal excitotoxic damage [119], besides Ca2+ other factors such as Na+ 
and Cl- influx, K+ efflux and swelling induce excitotoxic neuronal damage.  
Excessive [Ca2+]i ultimately leads to the generation of ROS, cytoskeletal degradation 
and the misfolding of proteins. A number of adaptations delimit some of these adverse 
consequences. [99]. All these species can be eliminated by two antioxidant mechanisms: 
a) molecules such as vitamin C, E, and A, selenium and glutathion; and b) several 
enzymes like superoxide dismutase, quinone reductase and, the most abundant, 
astroglial glutathion peroxidase. All of these systems are activated after an acute injury 
and many of them interfere with glutamate neurotramsmission [99].  
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Research on calcium precipitation and neuronal suffering is limited, besides the interest 
of future developments based on the easiness of its detection. For example, in vivo 
calcification detection would help identify amyloid plaque formation in Alzheimer’s 
disease or stroke, characterize the localization and extension of brain damage after 
hypoxia-ischemia, and facilitate the follow-up of the lesion [120]. 
 
Enhancement of neuronal energetics 
Synaptic increase of glutamate level, when not coupled to a heightened energy 
production, renders neurons susceptible to death. Astrocyte uptake and recycling of 
synaptic glutamate, as glutamine, is a major pathway dependent on energy metabolism. 
This dependency, not fully understood remains controversial. Under control conditions, 
the stoichiometric coupling of glutamatergic activity and glucose metabolism accounts 
for 80% of total cerebral glucose [91]. Part of this energy is needed for glutamate 
recycling in a coordinated process involving astrocytes and neurons, with 15% of brain 
oxidative metabolism contributed by astroglia [121]. Reduced energy availability 
leading to altered glutamate activity may thus be involved in apoptotic or necrotic 
neuronal death [87;122]. As revealed by nuclear magnetic resonance studies, glutamate 
uptake by astrocytes and its return to neurons as glutamine is a major metabolic 
pathway that reflects most of the cerebral glutamatergic activity [86;91;123]. Finally, 
the maintenance of lactate deshydrogenase activity in an excitotoxic hippocampal lesion 
with a 55% of neuronal loss [112], may reflect an astrocyte adaptation to heightened 
lactate availability to neurons.  
Some protective responses to over-stimulation target the energetic vulnerability. At this 
point, any progress to understand the astroglial contribution for neuronal energy 
metabolism will be crucial to explain some of these adaptative mechanisms. It is a 
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general agreement that an increase in glucose transport is protective in brain tissue 
following an insult. Several pieces of evidence have been reported supporting this 
statement. The described adaptative mechanisms include an increase in perfusion rate 
and recruitment of capillaries; stimulation of glial uptake of glucose and glycogenolysis, 
and an enhancement of glucose uptake and release of adenosine and lactate, increasing 
lactate metabolic pathway [99]. Thus, after an excitotoxic insult glia takes up glucose 
and converts it to lactate, which is delivered to neurons as an energy substrate [86].  
 
Uncoupling of the retaliatory systems and energy availability 
The tuning between retaliatory system actions and energy metabolism constitutes a fine 
equilibrium in physiological conditions, but it can be broken by neuronal over-
stimulation and then participate of the evoked neurodegenerative process. For example, 
AMPA-microinjection in medial septum, induces a progressive cholinergic and 
GABAergic loss associated to a long-term decline of the hippocampal functions 
[124;125], and decreased glutamatergic activity. Other effects of this lesion imply 
modifications of adenosine and taurine transmissions, glutamate recycling and glucose 
metabolism [81;112]. With time, adenosine replaces GABA functions to avoid further 
excitotoxic damage when cholinergic and GABAergic processes are compromised.  
The long-term septal lesion-induced neuronal loss in hippocampus is apoptotic with 
enhancement of neuronal glycolisis (Fig. 5). Together with a cleavage of caspase 3, a 
glutamate-glutamine cycle displacement towards glutamine production reduces 
glutamate synthesis [112]. In addition, synaptic glutamine is decreased, probably 
expelled to vessels, where it exerts a vasodilatory effect through nitric oxide synthesis 
inhibition [126]. In this situation the reduction in glutamate signaling and increased 
neuronal energy metabolism reflect a neurodegenerative process with a deficient 
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adaptation of the retaliatory systems and a chronic energy requirement to execute the 
apoptotic program. 
 
Fig. 5: Schematic drawing of glutamatergic synapse adaptation of the astrocyte-neuron 
interactions to neurodegeneration. The increased demand of neuronal energy implies a 
massive lactate formation in astrocytes, a reduced astrocyte activity centered in the 
uptake of glutamate and glutamine synthesis. Adaptation of the Glu/Gln cycle and 
neuronal energy metabolism is a key factor in the subsequent demise of the neuron. In 
physiological situations, increased GA (Glutaminase) activity directly correlates with 
increased GS (Glutamine synthase) activity, and the cycle recycles glutamate. In 
neurodegeneration, the GA/GS activities relationship is transformed into an inverse 
correlation that becomes negative toward a reduced glutamate formation and a net 
glutamine output. The heightened glutamine production is considered a neuroprotective 
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adaptation that allows perivascular astrocyte either to remove ammonia or to reduce 
glutamate released by injured neurons. Increased neuronal glycolysis taking place 
ultaneously helps sustain the surviving neurons. 
 
ENDURING EFFECTS OF SYNAPTIC OVERSTIMULTION 
If the compensatory mechanisms are not effective enough, the initial neuronal acute 
injury due to [Ca2+]i increase results, with time, in a chronic lesion. Disturbance of 
calcium homeostasis is part of all neurodegenerative disorders and in vivo and in vitro 
studies have shown an association between Ca2+ influx into neurons and 
neurodegeneration. Dysregulation of Ca2+ homeostasis alters the rapid and coherent 
activation of neurons and therefore is ultimately responsible for many aspects of brain 
dysfunction and central nervous system diseases. For example, an increased rate of 
Ca2+-mediated apoptosis may cause neuronal death in the penumbra of cerebral 
ischemia, or may underlie the etiology of chronic neurodegenerative disorders such as 
Parkinson and Alzheimer’s disease. Calcium precipitation that coincides with microglial 
activation, amyloid deposits and other ions accumulation in Alzheimer’s disease may 
thus be a key element of the neurodegenerative process.  
When an acute brain damage activates a neurodegenerative process its further 
progression will be related to the intensity of the initial injury. An on-going process 
with progressive neuronal loss may also be triggered by reiterative sustained neuronal 
over-stimulation. Acute neurological injury and chronic brain damage has been related 
in boxing participants, with a correlation in the prevalence of subdural hematoma and 
dementia pugilistica [127;128]. The same occurs with the disruption of the blood brain 
barrier induced by epileptic focus that triggers delayed neurodegeneration and 
functional brain impairment [129]. Cerebrovascular diseases and ischemia-reperfusion 
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processes might also be central in Alzheimer’s disease pathogenesis [130-132]}. Long-
term effects of drug dependence underlie an excitotoxicity process linked to a 
polysynaptic pathway that dynamically regulates synaptic glutamate, and subsequently 
its dysregulation with modifications of metabotropic, AMPA or NMDA receptor 
activity. The increased interest in glutamate-based strategies has evidenced promising 
results [133]. Clinical results with NMDA receptor antagonists such as memantine 
indicate a decrease of morphine intake in addict; promising results have also been 
obtained to treat withdrawal syndromes from opioids, alcohol and other sedatives [134]. 
In addition, blockade of mGluR5 with methyl-6-phenylethymiyl-pyridine may help 
control the behavioural effects of cocaine, nicotine and alcohol [135-137] and argue for 
the presence of a chronic neurodegenerative process. However, as said elsewhere, the 
differences observed in the glutamatergic synapse components in response to acute or 
chronic exposure to drug abuse and withdrawal are open questions that need to be 
investigated. 
 
CONCLUSIONS 
Variations in CNS acute damage after a similar over-stimulation underlie differences in 
neuronal populations, abundance and distribution of glutamate receptor subtypes and 
glial adaptation. This variability determines the induction of a chronic process that 
develops with distinct neurodegenerative parameters. Thus, at the tissue level, the 
response to the initial injury can be initially limited by adaptive mechanisms, or produce 
a variety of lesions related to the neuronal type involved, synaptic density, glial 
interactions, and vicinity of vascularization. For each neuron and astrocyte type the 
crew of AMPA/kainate, NMDA and metabotropic glutamate receptors, the Ca2+ binding 
protein content, protein phosphorylation levels, and all elements that participate in 
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energetic needs and glucose availability will be the factors involved in the appearance 
of the lesion. Thus, long-term effects of drug dependence are associated with an 
excitotoxicity process linked to a polysynaptic pathway that dynamically regulates 
synaptic glutamate. As described in this paper, retaliatory mechanisms include energy 
capability of the neurons, inhibitory systems and cytoplasmic calcium precipitation as 
part of the neuron-glia interactions. Their relationship and interdependence help explain 
the progressive decline of brain functions and bring new targets for therapeutic 
intervention. However, a better understanding of the complex interactions between 
cross-link circuits in acute and chronic models of drugs of abuse remains necessary. 
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FUTURE RESEARCH QUESTIONS 
The authors consider the following points as the more important questions to answer in 
future research approaches to determine the cellular and molecular basis of drug abuse 
and neurodegeneration. 
1.- Development of new in vivo models of drug abuse to differentiate between acute and 
chronic exposure; acute and repeated withdrawal; between low and high dose drug 
exposure; gender influence 
2.- Use of animal models of neurodegeneration to identify and validate new therapeutic 
targets from glutamatergic neurotransmission and retaliatory systems in acute and 
chronic drug abuse; acute and repeated withdrawal 
3.- Brain calcification and acute and chronic drug abuse 
4.- CNS development, Aging and drug addiction 
5.- Female versus male in development of drug addiction and withdrawal 
 
KEY OBJECTIVES 
This review deals the following learning objectives:  
1.- To understand the cellular and molecular types of adaptation to long-lived aspects of 
addiction and withdrawal 
2.- To establish the relationship between acute drug abuse, formation of calcium 
precipitates and neuronal death.  
3.- To establish the relationship between drug enduring effects, activation of glutamate 
receptors, glia response and neurodegeneration. 
4.- To get an integrated view of how a drug interferes the energy capability of neurons, 
the neuron-glia interactions and the inhibitory systems aimed at the control of acute and 
chronic over-stimulation. 
